Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
Sign Up to like & getrecommendations! Published in 2020 at "Drug Safety"
DOI: 10.1007/s40264-020-01026-y
Abstract: N-Acetylcysteine (NAC) is widely used in respiratory medicine, with a maximum licensed dose in chronic use of 600 mg/day; however, some clinical trials have studied the efficacy of NAC at higher doses. The aim of… read more here.
Keywords: safety; safety acetylcysteine; acetylcysteine high; respiratory diseases ... See more keywords